Elizabeth A. Eklund
Affiliations: | Northwestern University, Evanston, IL |
Area:
Cell Biology, Molecular Biology, OncologyGoogle:
"Elizabeth Eklund"Children
Sign in to add traineeStephan C. Lindsey | grad student | 2006 | Northwestern |
Iwona M. Konieczna | grad student | 2010 | Northwestern |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Khan I, Amin MA, Eklund EA, et al. (2024) Regulation of HOX gene expression in AML. Blood Cancer Journal. 14: 42 |
Chen H, Bai Y, Kobayashi M, et al. (2023) PRL2 phosphatase promotes oncogenic KIT signaling in leukemia cells through modulating CBL phosphorylation. Molecular Cancer Research : McR |
Williams O, Hu L, Huang W, et al. (2023) Nore1 inhibits age-associated myeloid lineage skewing and clonal hematopoiesis but facilitates termination of emergency (stress) granulopoiesis. The Journal of Biological Chemistry. 299: 104867 |
Chen H, Bai Y, Kobayashi M, et al. (2022) PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371. Blood |
Suarez M, Blyth GT, Mina AA, et al. (2021) Inhibitory effects of Tomivosertib in acute myeloid leukemia. Oncotarget. 12: 955-966 |
Khan I, Eklund EA, Gartel AL. (2020) Therapeutic vulnerabilities of transcription factors in AML. Molecular Cancer Therapeutics |
Wang H, Shah CA, Hu L, et al. (2020) An aberrantly sustained emergency granulopoiesis response accelerates post chemotherapy relapse in MLL1-rearranged acute myeloid leukemia in mice. The Journal of Biological Chemistry |
Huang W, Liu B, Eklund EA. (2020) Investigating the role of the innate immune response in relapse or blast crisis in chronic myeloid leukemia. Leukemia |
Kosciuczuk EM, Kar AK, Blyth GT, et al. (2019) Inhibitory effects of SEL201 in acute myeloid leukemia. Oncotarget. 10: 7112-7121 |
Beauchamp EM, Abedin SM, Radecki SG, et al. (2018) Identification and targeting of novel CDK9 complexes in acute myeloid leukemia. Blood |